Extracellular production of human cystatin S and cystatin SA by Bacillus subtilis

被引:10
作者
Akiba, Shunichi
Hayashi, Yasuhiro
Hakamada, Yoshihiro
Endo, Keiji
Ara, Katsutoshi
Kawai, Shuji
Saitoh, Eiichi
机构
[1] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan
[2] Niigata Inst Technol, Dept Appl Chem & Biotechnol, Niigata 9451145, Japan
关键词
Bacillus subtilis; endoglucanase; human salivary cystatin;
D O I
10.1016/j.pep.2006.04.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We herein describe the development of a Bacillus subtilis system that can be used to produce large quantities of recombinant (r-) human salivary cystatins, a cysteine protease inhibitor of family 2 in the cystatin superfamily. The B. subtilis that lacked the alkaline protease E gene (Delta aprE type mutant strain) was prepared by homologous recombination. The cDNA fragments coding for mature cystatins (S and SA) were ligated in frame to the DNA segment for the signal peptide of endoglucanase in the pHSP-US plasmid vector that was then use to transform the Delta aprE type mutant strain of B. subtilis. The transformants carrying the expression vectors were cultivated in 5-L jar fermenters for 3 days at 30 degrees C. Both r-cystatin S and r-cystatin SA were successfully expressed and secreted into the culture broth, and were purified using a fast performance liquid chromatography system. The first use of Delta aprE type mutant strain of B. subtilis made it possible to obtain a high yield of secreted protein, which makes this system an improvement over expression in Escherichia coli. We conclude that this system has high utility for expression of commercial quantities of secreted proteins. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 41 条
  • [1] Cystatins
    Abrahamson, M
    Alvarez-Fernandez, M
    Nathanson, CM
    [J]. PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 : 179 - 199
  • [2] NOMENCLATURE AND CLASSIFICATION OF THE PROTEINS HOMOLOGOUS WITH THE CYSTEINE-PROTEINASE INHIBITOR CHICKEN CYSTATIN
    BARRETT, AJ
    FRITZ, H
    GRUBB, A
    ISEMURA, S
    JARVINEN, M
    KATUNUMA, N
    MACHLEIDT, W
    MULLERESTERL, W
    SASAKI, M
    TURK, V
    [J]. BIOCHEMICAL JOURNAL, 1986, 236 (01) : 312 - 312
  • [3] Examination of the potential structure of human salivary cystatins based on computer modelling
    Bell, JE
    Cunningham, E
    Belt, C
    Featherstone, JDB
    Bell, J
    [J]. ARCHIVES OF ORAL BIOLOGY, 1997, 42 (10-11) : 761 - 772
  • [4] BJORCK L, 1990, J VIROL, V64, P941
  • [5] Blankenvoorde MFJ, 1996, BIOL CHEM, V377, P847
  • [6] Blankenvoorde MFJ, 1998, BIOL CHEM, V379, P1371
  • [7] BIOLOGICAL-ACTIVITIES AND SECONDARY STRUCTURES OF VARIANT FORMS OF HUMAN SALIVARY CYSTATIN SN PRODUCED IN ESCHERICHIA-COLI
    BOBEK, LA
    RAMASUBBU, N
    WANG, XH
    WEAVER, TR
    LEVINE, MJ
    [J]. GENE, 1994, 151 (1-2) : 303 - 308
  • [8] HIGH-FREQUENCY TRANSFORMATION OF BACILLUS-SUBTILIS PROTOPLASTS BY PLASMID DNA
    CHANG, S
    COHEN, SN
    [J]. MOLECULAR & GENERAL GENETICS, 1979, 168 (01): : 111 - 115
  • [9] High-level production of recombinant chicken cystatin by Pichia pastoris and its application in mackerel surimi
    Chen, GH
    Tang, SJ
    Chen, CS
    Jiang, ST
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (02) : 641 - 646
  • [10] Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration
    Collins, AR
    Grubb, A
    [J]. ORAL MICROBIOLOGY AND IMMUNOLOGY, 1998, 13 (01): : 59 - 61